Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Dan

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Antioxidants (Basel, Switzerland)|April 30, 2021
Accumulation of Carbonyl Proteins in the Brain of Mouse Model for Methylglyoxal Detoxification DeficitsShin Koike, Kazuya Toriumi, Sakura Kasahara, et al.
Drug Metabolism and Pharmacokinetics|April 29, 2018
Points-to-consider documents: Scientific information on the evaluation of genetic polymorphisms during non-clinical studies and phase I clinical trials in the Japanese populationMasahiro Hiratsuka, Noriyasu Hirasawa, Yoshiteru Oshima, et al.
Nephrology (Carlton, Vic.)|August 29, 2009
Very high doses of valsartan provide renoprotection independently of blood pressure in a type 2 diabetic nephropathy rat modelNaoto Tominaga, Annie Robert, Yuko Izuhara, et al.
Expert Opinion on Investigational Drugs|November 12, 2013
Neovascularization induced by hypoxia inducible transcription factor is associated with the improvement of cardiac dysfunction in experimental autoimmune myocarditisYuko Tada, Masahito Ogawa, Ryo Watanabe, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 21, 2010
A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primatesYuko Izuhara, Nagahisa Yamaoka, Hidehiko Kodama, et al.
Kidney International|June 27, 2008
The role of megsin, a serine protease inhibitor, in diabetic mesangial matrix accumulationShuichi Ohtomo, Masaomi Nangaku, Yuko Izuhara, et al.
Cancer Biology & Therapy|January 15, 2015
Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancerSatsuki Mashiko, Kazuyuki Kitatani, Masafumi Toyoshima, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 29, 2008
A novel Sartan derivative with very low angiotensin II type 1 receptor affinity protects the kidney in type 2 diabetic ratsYuko Izuhara, Toshio Sada, Hiroaki Yanagisawa, et al.
Molecules (Basel, Switzerland)|April 12, 2018
Furan- and Thiophene-2-Carbonyl Amino Acid Derivatives Activate Hypoxia-Inducible Factor via Inhibition of Factor Inhibiting Hypoxia-Inducible Factor-1Shin-Ichi Kawaguchi, Yuhei Gonda, Takuya Yamamoto, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 9, 2017
Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in miceKumpei Honjo, Shinya Munakata, Yoshihiko Tashiro, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Antioxidants (Basel, Switzerland)|April 30, 2021
Accumulation of Carbonyl Proteins in the Brain of Mouse Model for Methylglyoxal Detoxification DeficitsShin Koike, Kazuya Toriumi, Sakura Kasahara, et al.
Drug Metabolism and Pharmacokinetics|April 29, 2018
Points-to-consider documents: Scientific information on the evaluation of genetic polymorphisms during non-clinical studies and phase I clinical trials in the Japanese populationMasahiro Hiratsuka, Noriyasu Hirasawa, Yoshiteru Oshima, et al.
Nephrology (Carlton, Vic.)|August 29, 2009
Very high doses of valsartan provide renoprotection independently of blood pressure in a type 2 diabetic nephropathy rat modelNaoto Tominaga, Annie Robert, Yuko Izuhara, et al.
Expert Opinion on Investigational Drugs|November 12, 2013
Neovascularization induced by hypoxia inducible transcription factor is associated with the improvement of cardiac dysfunction in experimental autoimmune myocarditisYuko Tada, Masahito Ogawa, Ryo Watanabe, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 21, 2010
A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primatesYuko Izuhara, Nagahisa Yamaoka, Hidehiko Kodama, et al.
Kidney International|June 27, 2008
The role of megsin, a serine protease inhibitor, in diabetic mesangial matrix accumulationShuichi Ohtomo, Masaomi Nangaku, Yuko Izuhara, et al.
Cancer Biology & Therapy|January 15, 2015
Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancerSatsuki Mashiko, Kazuyuki Kitatani, Masafumi Toyoshima, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 29, 2008
A novel Sartan derivative with very low angiotensin II type 1 receptor affinity protects the kidney in type 2 diabetic ratsYuko Izuhara, Toshio Sada, Hiroaki Yanagisawa, et al.
Molecules (Basel, Switzerland)|April 12, 2018
Furan- and Thiophene-2-Carbonyl Amino Acid Derivatives Activate Hypoxia-Inducible Factor via Inhibition of Factor Inhibiting Hypoxia-Inducible Factor-1Shin-Ichi Kawaguchi, Yuhei Gonda, Takuya Yamamoto, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 9, 2017
Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in miceKumpei Honjo, Shinya Munakata, Yoshihiko Tashiro, et al.
Pageof 3